RCM
TECH icon

Raleigh Capital Management’s Bio-Techne TECH Stock Holding History

Raleigh Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105
Closed -$7.56K – 1003
2024
Q4 		$7.56K Buy
105
+25
+31% +$1.84K ﹤0.01% 648
2024
Q3 		$6.39K Hold
80
– – ﹤0.01% 667
2024
Q2 		$5.73K Buy
80
+15
+23% +$1.1K ﹤0.01% 659
2024
Q1 		$4.58K Buy
65
+50
+333% +$3.58K ﹤0.01% 671
2023
Q4 		$1.16K Buy
+15
New +$988 ﹤0.01% 924

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Raleigh Capital Management's TECH Position: Q1 2025 in Review

Raleigh Capital Management sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 105 shares — an estimated $7.56K sold.

Raleigh Capital Management first reported a position in TECH in Q4 2023 and held it in 5 quarters. The position peaked at $7.56K in Q4 2024. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Raleigh Capital Management reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 105 Bio-Techne shares in Q1 2025, an estimated $7.56K.
  • Raleigh Capital Management first reported a position in Bio-Techne in Q4 2023 and held it in 5 quarters.
  • Raleigh Capital Management's Bio-Techne position peaked at $7.56K in Q4 2024.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.